{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:22:53Z","timestamp":1793712173837,"version":"4.6.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13017-z","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T14:24:40Z","timestamp":1755613480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unlocking the antimalarial potential of novel steroid-tetraoxane hybrids through consensus molecular docking and molecular dynamics investigation"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0038-1195","authenticated-orcid":false,"given":"Dipankar","family":"Nath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1056-1197","authenticated-orcid":false,"given":"Abhijit","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malita","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0417-0627","authenticated-orcid":false,"given":"Rajesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Chetia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"13017_CR1","doi-asserted-by":"publisher","first-page":"a025569","DOI":"10.1101\/cshperspect.a025569","volume":"8","author":"DA Milner","year":"2018","unstructured":"Milner, D. A. Malaria pathogenesis. Cold Spring Harb Perspect. Med. 8, a025569 (2018).","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"13017_CR2","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/S1473-3099(24)00091-4","volume":"24","author":"S Bagcchi","year":"2024","unstructured":"Bagcchi, S. Climate change recognised in world malaria report 2023. Lancet Infect. Dis. 24, e157 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"13017_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","volume":"93","author":"L Cui","year":"2015","unstructured":"Cui, L., Mharakurwa, S., Ndiaye, D., Rathod, P. K. & Rosenthal, P. J. Antimalarial drug resistance: literature review and activities and findings of the ICEMR network. Am. J. Trop. Med. Hyg. 93, 57\u201368 (2015).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"13017_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","volume":"77","author":"F Nosten","year":"2007","unstructured":"Nosten, F. & White, N. J. Artemisinin-based combination treatment of falciparum malaria. Am. J. Trop. Med. Hyg. 77, 181\u2013192 (2007).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"13017_CR5","doi-asserted-by":"publisher","first-page":"c2637","DOI":"10.1136\/bmj.c2637","volume":"340","author":"H Reyburn","year":"2010","unstructured":"Reyburn, H. New WHO guidelines for the treatment of malaria. BMJ 340, c2637\u2013c2637 (2010).","journal-title":"BMJ"},{"key":"13017_CR6","doi-asserted-by":"publisher","first-page":"117339","DOI":"10.1016\/j.bmc.2023.117339","volume":"88\u201389","author":"T Umumararungu","year":"2023","unstructured":"Umumararungu, T. et al. Recent developments in antimalarial drug discovery. Bioorg. Med. Chem. 88\u201389, 117339 (2023).","journal-title":"Bioorg. Med. Chem."},{"key":"13017_CR7","doi-asserted-by":"publisher","first-page":"e0039222","DOI":"10.1128\/aac.00392-22","volume":"66","author":"A Chaurasiya","year":"2022","unstructured":"Chaurasiya, A. et al. Targeting artemisinin-resistant malaria by repurposing the anti-Hepatitis C virus drug alisporivir. Antimicrob. Agents Chemother. 66, e0039222 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"13017_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pep.2011.04.012","volume":"78","author":"A Mar\u00edn-Men\u00e9ndez","year":"2011","unstructured":"Mar\u00edn-Men\u00e9ndez, A. & Bell, A. Overexpression, purification and assessment of cyclosporin binding of a family of cyclophilins and cyclophilin-like proteins of the human malarial parasite plasmodium falciparum. Protein Exp. Purif. 78, 225\u2013234 (2011).","journal-title":"Protein Exp. Purif."},{"key":"13017_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.molbiopara.2012.04.006","volume":"184","author":"A Mar\u00edn-Men\u00e9ndez","year":"2012","unstructured":"Mar\u00edn-Men\u00e9ndez, A., Monaghan, P. & Bell, A. A family of cyclophilin-like molecular chaperones in plasmodium falciparum. Mol. Biochem. Parasitol. 184, 44\u201347 (2012).","journal-title":"Mol. Biochem. Parasitol."},{"key":"13017_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ar7000843","volume":"41","author":"B Meunier","year":"2008","unstructured":"Meunier, B. Hybrid molecules with a dual mode of action: dream or reality? Acc. Chem. Res. 41, 69\u201377 (2008).","journal-title":"Acc. Chem. Res."},{"key":"13017_CR11","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1021\/jm020891g","volume":"45","author":"BA Solaja","year":"2002","unstructured":"Solaja, B. A. et al. Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity. J. Med. Chem. 45, 3331\u20133336 (2002).","journal-title":"J. Med. Chem."},{"key":"13017_CR12","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1016\/j.bmcl.2007.05.055","volume":"17","author":"C Singh","year":"2007","unstructured":"Singh, C., Sharma, U., Saxena, G. & Puri, S. K. Orally active antimalarials: synthesis and bioevaluation of a new series of steroid-based 1,2,4-trioxanes against multi-drug resistant malaria in mice. Bioorg. Med. Chem. Lett. 17, 4097\u20134101 (2007).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"13017_CR13","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.bmcl.2011.01.103","volume":"21","author":"MC Lombard","year":"2011","unstructured":"Lombard, M. C., N\u2019Da, D. D., Breytenbach, J. C., Smith, P. J. & Lategan, C. A. Synthesis, in vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids. Bioorg. Med. Chem. Lett. 21, 1683\u20131686 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"13017_CR14","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1128\/AAC.05133-11","volume":"55","author":"R Capela","year":"2011","unstructured":"Capela, R. et al. Design and evaluation of Primaquine-Artemisinin hybrids as a multistage antimalarial strategy. Antimicrob. Agents Chemother. 55, 4698\u20134706 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"13017_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bmc.2012.10.019","volume":"21","author":"SI Pretorius","year":"2013","unstructured":"Pretorius, S. I., Breytenbach, W. J., De Kock, C., Smith, P. J. & N\u2019Da, D. D. Synthesis, characterization and antimalarial activity of quinoline\u2013pyrimidine hybrids. Bioorg. Med. Chem. 21, 269\u2013277 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"13017_CR16","doi-asserted-by":"publisher","first-page":"20729","DOI":"10.1039\/C4RA02276A","volume":"4","author":"A Thakur","year":"2014","unstructured":"Thakur, A., Khan, S. I. & Rawat, D. S. Synthesis of piperazine tethered 4-aminoquinoline-pyrimidine hybrids as potent antimalarial agents. RSC Adv. 4, 20729\u201320736 (2014).","journal-title":"RSC Adv."},{"key":"13017_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.steroids.2017.11.008","volume":"129","author":"EY Yamansarov","year":"2018","unstructured":"Yamansarov, E. Y. et al. Synthesis and antimalarial activity of 3\u2019-trifluoromethylated 1,2,4-trioxolanes and 1,2,4,5-tetraoxane based on deoxycholic acid. Steroids 129, 17\u201323 (2018).","journal-title":"Steroids"},{"key":"13017_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1515\/chem-2020-0027","volume":"18","author":"I Indriani","year":"2020","unstructured":"Indriani, I., Aminah, N. S. & Puspaningsih, N. N. T. Antiplasmodial activity of stigmastane steroids from Dryobalanops oblongifolia stem bark. Open. Chem. 18, 259\u2013264 (2020).","journal-title":"Open. Chem."},{"key":"13017_CR19","doi-asserted-by":"crossref","unstructured":"Raju, J. & V., C. Diosgenin, a Steroid Saponin Constituent of Yams and Fenugreek: Emerging Evidence for Applications in Medicine. in Bioactive Compounds in Phytomedicine (ed. Rasooli, I.)InTech, (2012).","DOI":"10.5772\/26700"},{"key":"13017_CR20","doi-asserted-by":"crossref","unstructured":"Anti-malaria and hypoglycaemic activities of Diosgenin on alloxan-induced, diabetic Wistar rats. GSC Biol. Pharm. Sci. 15, 073\u2013079 (2021).","DOI":"10.30574\/gscbps.2021.15.3.0102"},{"key":"13017_CR21","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.3390\/molecules18033356","volume":"18","author":"A Pab\u00f3n","year":"2013","unstructured":"Pab\u00f3n, A. et al. Diosgenone synthesis, anti-Malarial activity and QSAR of analogues of this natural product. Molecules 18, 3356\u20133378 (2013).","journal-title":"Molecules"},{"key":"13017_CR22","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/s44321-024-00087-1","volume":"16","author":"M Fraser","year":"2024","unstructured":"Fraser, M. et al. Harnessing cholesterol uptake of malaria parasites for therapeutic applications. EMBO Mol. Med. 16, 1515\u20131532 (2024).","journal-title":"EMBO Mol. Med."},{"key":"13017_CR23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1080\/14756366.2017.1363742","volume":"32","author":"M Rudrapal","year":"2017","unstructured":"Rudrapal, M., Chetia, D. & Singh, V. Novel series of 1,2,4-trioxane derivatives as antimalarial agents. J. Enzyme Inhib. Med. Chem. 32, 1159\u20131173 (2017).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"13017_CR24","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1021\/ci800081s","volume":"48","author":"J Koska","year":"2008","unstructured":"Koska, J. et al. Fully automated molecular mechanics based induced fit protein-ligand Docking method. J. Chem. Inf. Model. 48, 1965\u20131973 (2008).","journal-title":"J. Chem. Inf. Model."},{"key":"13017_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2174\/1573409052952314","volume":"1","author":"E Krovat","year":"2005","unstructured":"Krovat, E., Steindl, T. & Langer, T. Recent advances in Docking and scoring. Curr. Comput. Aided-Drug Des. 1, 93\u2013102 (2005).","journal-title":"Curr. Comput. Aided-Drug Des."},{"key":"13017_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2174\/1573406418666221012161111","volume":"19","author":"MK Kumawat","year":"2023","unstructured":"Kumawat, M. K., Kaur, R. & Kumar, K. In-Silico prediction of novel fused Quinazoline based topoisomerase inhibitors as anticancer agents. Med. Chem. (Shariqah (United Arab. Emirates)). 19, 431\u2013444 (2023).","journal-title":"Med. Chem. (Shariqah (United Arab. Emirates))"},{"key":"13017_CR27","unstructured":"In Silico Evaluation of Novel 2-Pyrazoline Carboxamide Derivatives as Potential Protease Inhibitors Against Plasmodium Parasites. in."},{"key":"13017_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.steroids.2008.01.012","volume":"73","author":"KQ Shawakfeh","year":"2008","unstructured":"Shawakfeh, K. Q., Al-Said, N. H. & Al-Zoubi, R. M. Synthesis of bis-diosgenin pyrazine dimers: new cephalostatin analogs. Steroids 73, 579\u2013584 (2008).","journal-title":"Steroids"},{"key":"13017_CR29","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/1758-2946-3-S1-P3","volume":"3","author":"B Karulin","year":"2011","unstructured":"Karulin, B. & Kozhevnikov, M. Ketcher: web-based chemical structure editor. J. Cheminform. 3, P3 (2011).","journal-title":"J. Cheminform."},{"key":"13017_CR30","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander, T., Freyss, J., Von Korff, M. & Rufener, C. DataWarrior: an open-source program for chemistry aware data visualization and analysis. J. Chem. Inf. Model. 55, 460\u2013473 (2015).","journal-title":"J. Chem. Inf. Model."},{"key":"13017_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","volume":"4","author":"GR Bickerton","year":"2012","unstructured":"Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S. & Hopkins, A. L. Quantifying the chemical beauty of drugs. Nat. Chem. 4, 90\u201398 (2012).","journal-title":"Nat. Chem."},{"key":"13017_CR32","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong, G. et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 49, W5\u2013W14 (2021).","journal-title":"Nucleic Acids Res."},{"key":"13017_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NMO Boyle","year":"2011","unstructured":"Boyle, N. M. O. et al. Open babel: an open chemical toolbox. J. Cheminform. 3, 1\u201314 (2011).","journal-title":"J. Cheminform."},{"key":"13017_CR34","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"13017_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/jmbi.2000.3633","volume":"298","author":"MR Peterson","year":"2000","unstructured":"Peterson, M. R. et al. The three-dimensional structure of a Plasmodium falciparum Cyclophilin in complex with the potent anti-malarial cyclosporin A1. J. Mol. Biol. 298, 123\u2013133 (2000).","journal-title":"J. Mol. Biol."},{"key":"13017_CR36","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: new Docking methods, expanded force field, and python bindings. J. Chem. Inf. Model. 61, 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"13017_CR37","doi-asserted-by":"publisher","unstructured":"Trott, O. & Olson, A. J. AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. NA-NA https:\/\/doi.org\/10.1002\/jcc.21334 (2009).","DOI":"10.1002\/jcc.21334"},{"key":"13017_CR38","doi-asserted-by":"publisher","first-page":"012143","DOI":"10.1088\/1755-1315\/218\/1\/012143","volume":"218","author":"N Liu","year":"2019","unstructured":"Liu, N. & Xu, Z. Using LeDock as a Docking tool for computational drug design. IOP Conf. Ser.: Earth Environ. Sci. 218, 012143 (2019).","journal-title":"IOP Conf. Ser.: Earth Environ. Sci."},{"key":"13017_CR39","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1093\/bioinformatics\/btv082","volume":"31","author":"A Alhossary","year":"2015","unstructured":"Alhossary, A., Handoko, S. D., Mu, Y. & Kwoh, C. K. Fast, accurate, and reliable molecular Docking with QuickVina 2. Bioinformatics 31, 2214\u20132216 (2015).","journal-title":"Bioinformatics"},{"key":"13017_CR40","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"13017_CR41","doi-asserted-by":"publisher","unstructured":"Li, H., S Leung, K. & H Wong, M. Idock: A multithreaded virtual screening tool for flexible ligand Docking. 2012 IEEE Symp. Comput. Intell. Comput. Biology CIBCB 2012. 77-84 https:\/\/doi.org\/10.1109\/CIBCB.2012.6217214 (2012).","DOI":"10.1109\/CIBCB.2012.6217214"},{"key":"13017_CR42","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/ci300604z","volume":"53","author":"DR Koes","year":"2013","unstructured":"Koes, D. R., Baumgartner, M. P. & Camacho, C. J. Lessons learned in empirical scoring with Smina from the CSAR 2011 benchmarking exercise. J. Chem. Inf. Model. 53, 1893\u20131904 (2013).","journal-title":"J. Chem. Inf. Model."},{"key":"13017_CR43","doi-asserted-by":"publisher","first-page":"e0313830","DOI":"10.1371\/journal.pone.0313830","volume":"20","author":"A Debnath","year":"2025","unstructured":"Debnath, A., Mazumder, R., Singh, A. K. & Singh, R. K. Identification of novel cyclin-dependent kinase 4\/6 inhibitors from marine natural products. PLoS One. 20, e0313830 (2025).","journal-title":"PLoS One"},{"key":"13017_CR44","doi-asserted-by":"publisher","unstructured":"Debnath, A. et al. Quest for Discovering Novel CDK12 Inhibitor by Leveraging High-Throughput Virtual Screening. https:\/\/www.researchsquare.com\/article\/rs-3382004\/v1 (2023). https:\/\/doi.org\/10.21203\/rs.3.rs-3382004\/v1","DOI":"10.21203\/rs.3.rs-3382004\/v1"},{"key":"13017_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter, J. D. & Matplotlib A 2D graphics environment. Comput. Sci. Eng. 9, 90\u201395 (2007).","journal-title":"Comput. Sci. Eng."},{"key":"13017_CR46","doi-asserted-by":"publisher","unstructured":"The pandas development team. pandas-dev\/pandas: Pandas. [object Object] (2024). https:\/\/doi.org\/10.5281\/ZENODO.3509134","DOI":"10.5281\/ZENODO.3509134"},{"key":"13017_CR47","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"CR Harris","year":"2020","unstructured":"Harris, C. R. et al. Array programming with numpy. Nature 585, 357\u2013362 (2020).","journal-title":"Nature"},{"key":"13017_CR48","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: fast, flexible, and free. J. Comput. Chem. 26, 1701\u20131718 (2005).","journal-title":"J. Comput. Chem."},{"key":"13017_CR49","doi-asserted-by":"crossref","unstructured":"Debnath, A. et al. Discovery of Novel PTP1B Inhibitors by High-throughput Virtual Screening. CAD 21, (2024).","DOI":"10.2174\/0115734099278007241004105500"},{"key":"13017_CR50","doi-asserted-by":"publisher","first-page":"136807","DOI":"10.1016\/j.ijbiomac.2024.136807","volume":"282","author":"A Debnath","year":"2024","unstructured":"Debnath, A., Mazumder, R., Singh, R. K. & Singh, A. K. Discovery of novel CDK4\/6 inhibitors from fungal secondary metabolites. Int. J. Biol. Macromol. 282, 136807 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"13017_CR51","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang, J. & Mackerell, A. D. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J. Comput. Chem. 34, 2135\u20132145 (2013).","journal-title":"J. Comput. Chem."},{"key":"13017_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods. 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"13017_CR53","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1021\/ci300363c","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K. & MacKerell, A. D. Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing. J. Chem. Inf. Model. 52, 3144\u20133154 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"13017_CR54","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe, K. et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all\u2010atom additive biological force fields. J. Comput. Chem. 31, 671\u2013690 (2010).","journal-title":"J. Comput. Chem."},{"key":"13017_CR55","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1021\/jz501780a","volume":"5","author":"S Izadi","year":"2014","unstructured":"Izadi, S., Anandakrishnan, R. & Onufriev, A. V. Building water models: a different approach. J. Phys. Chem. Lett. 5, 3863\u20133871 (2014).","journal-title":"J. Phys. Chem. Lett."},{"key":"13017_CR56","doi-asserted-by":"publisher","first-page":"10096","DOI":"10.1063\/1.1808117","volume":"121","author":"DJ Price","year":"2004","unstructured":"Price, D. J. & Brooks, C. L. A modified TIP3P water potential for simulation with Ewald summation. J. Chem. Phys. 121, 10096\u201310103 (2004).","journal-title":"J. Chem. Phys."},{"key":"13017_CR57","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1021\/acs.jpcb.6b01316","volume":"120","author":"S Boonstra","year":"2016","unstructured":"Boonstra, S., Onck, P. R. & Van Der Giessen, E. CHARMM TIP3P water model suppresses peptide folding by solvating the unfolded state. J. Phys. Chem. B. 120, 3692\u20133698 (2016).","journal-title":"J. Phys. Chem. B"},{"key":"13017_CR58","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/jcc.21787","volume":"32","author":"N Michaud-Agrawal","year":"2011","unstructured":"Michaud-Agrawal, N., Denning, E. J., Woolf, T. B. & Beckstein, O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J. Comput. Chem. 32, 2319\u20132327 (2011).","journal-title":"J. Comput. Chem."},{"key":"13017_CR59","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","volume":"25","author":"PJA Cock","year":"2009","unstructured":"Cock, P. J. A. et al. Biopython: freely available python tools for computational molecular biology and bioinformatics. Bioinformatics 25, 1422\u20131423 (2009).","journal-title":"Bioinformatics"},{"key":"13017_CR60","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/bioinformatics\/btu829","volume":"31","author":"N Rego","year":"2015","unstructured":"Rego, N. & Koes, D. 3Dmol.js: molecular visualization with WebGL. Bioinformatics 31, 1322\u20131324 (2015).","journal-title":"Bioinformatics"},{"key":"13017_CR61","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13321-021-00548-6","volume":"13","author":"C Bouysset","year":"2021","unstructured":"Bouysset, C. & Fiorucci, S. ProLIF: a library to encode molecular interactions as fingerprints. J. Cheminform. 13, 72 (2021).","journal-title":"J. Cheminform."},{"key":"13017_CR62","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1093\/bioinformatics\/bty419","volume":"34","author":"AS Rose","year":"2018","unstructured":"Rose, A. S. et al. NGL viewer: web-based molecular graphics for large complexes. Bioinformatics 34, 3755\u20133758 (2018).","journal-title":"Bioinformatics"},{"key":"13017_CR63","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"13017_CR64","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee, P., Kemmler, E., Dunkel, M. & Preissner, R. ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 52, W513\u2013W520 (2024).","journal-title":"Nucleic Acids Res."},{"key":"13017_CR65","unstructured":"https:\/\/www.who.int\/publications\/i\/item\/9789240031357"},{"key":"13017_CR66","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12936-015-0684-5","volume":"14","author":"M Wahajuddin","year":"2015","unstructured":"Wahajuddin, M. et al. Simultaneous quantification of proposed anti-malarial combination comprising of lumefantrine and CDRI 97\u201378 in rat plasma using the HPLC\u2013ESI-MS\/MS method: application to drug interaction study. Malar. J. 14, 172 (2015).","journal-title":"Malar. J."},{"key":"13017_CR67","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/cid\/cis475","volume":"55","author":"N Valecha","year":"2012","unstructured":"Valecha, N. et al. Arterolane maleate plus Piperaquine phosphate for treatment of uncomplicated plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial. Clin. Infect. Dis. 55, 663\u2013671 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"13017_CR68","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/pharmaceutics12060509","volume":"12","author":"J Zech","year":"2020","unstructured":"Zech, J. et al. Oral administration of Artemisone for the treatment of schistosomiasis: formulation challenges and in vivo efficacy. Pharmaceutics 12, 509 (2020).","journal-title":"Pharmaceutics"},{"key":"13017_CR69","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/anie.200503071","volume":"45","author":"RK Haynes","year":"2006","unstructured":"Haynes, R. K. et al. Artemisone\u2014a highly active antimalarial drug of the Artemisinin class. Angew. Chem. Int. Ed. 45, 2082\u20132088 (2006).","journal-title":"Angew. Chem. Int. Ed."},{"key":"13017_CR70","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1473-3099(15)00320-5","volume":"16","author":"AP Phyo","year":"2016","unstructured":"Phyo, A. P. et al. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with plasmodium falciparum and plasmodium Vivax malaria: an open-label phase 2 trial. Lancet Infect. Dis. 16, 61\u201369 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"13017_CR71","unstructured":"Brit, J. C. Pharma \u2013\u20092012 - Moehrle - First-in-man Safety and Pharmacokinetics of Synthetic Ozonide OZ439 Demonstrates."},{"key":"13017_CR72","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1016\/j.bmcl.2012.04.100","volume":"22","author":"KV Sashidhara","year":"2012","unstructured":"Sashidhara, K. V. et al. Coumarin-trioxane hybrids: synthesis and evaluation as a new class of antimalarial scaffolds. Bioorg. Med. Chem. Lett. 22, 3926\u20133930 (2012).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"13017_CR73","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1021\/bi2004558","volume":"50","author":"MA Lill","year":"2011","unstructured":"Lill, M. A. Efficient incorporation of protein flexibility and dynamics into molecular docking simulations. Biochemistry 50, 6157\u20136169 (2011).","journal-title":"Biochemistry"},{"key":"13017_CR74","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1021\/acsinfecdis.2c00584","volume":"9","author":"HD Attram","year":"2023","unstructured":"Attram, H. D., Korkor, C. M., Taylor, D., Njoroge, M. & Chibale, K. Antimalarial imidazopyridines incorporating an intramolecular hydrogen bonding motif: medicinal chemistry and mechanistic studies. ACS Infect. Dis. 9, 928\u2013942 (2023).","journal-title":"ACS Infect. Dis."},{"key":"13017_CR75","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.chembiol.2023.04.006","volume":"30","author":"W Zhan","year":"2023","unstructured":"Zhan, W. et al. Dual-pharmacophore artezomibs hijack the plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance. Cell. Chem. Biol. 30, 457\u2013469e11 (2023).","journal-title":"Cell. Chem. Biol."},{"key":"13017_CR76","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","volume":"3","author":"M Mehta","year":"2023","unstructured":"Mehta, M. et al. Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development. ACS Mater. Au. 3, 600\u2013619 (2023).","journal-title":"ACS Mater. Au"},{"key":"13017_CR77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu, D. et al. The blood\u2013brain barrier: structure, regulation and drug delivery. Signal. Transduct. Target. Therapy. 8, 217 (2023).","journal-title":"Signal. Transduct. Target. Therapy"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13017-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13017-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13017-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:45:48Z","timestamp":1757411148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13017-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13017"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13017-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Figures submitted with the manuscript have been generated by the authors themselves and have not been copied or adapted from other sources. The standard of the English language in this article has been enhanced using LLMs, namely Llama-2-70B-GGML and OpenAI\u2019s chatbot, Chat Generative Pre-trained Transformer 4.0. We bear full responsibility for the contents of this publication. We have conducted a comprehensive examination, made improvements, and refined all languages generated by the LLM to ensure their precise alignment with our initial research outcomes and interpretations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The study does not contain data from any person.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}],"article-number":"30389"}}